Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
EPCORE™FL-2
A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCORE™FL-2)
2 other identifiers
interventional
1,095
31 countries
264
Brief Summary
Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease recurs in almost all patients. This study will assess how safe and effective epcoritamab is in combination with lenalidomide and rituximab (R2) in treating adult participants with previously untreated FL. Adverse events and change in disease condition will be assessed. Epcoritamab is an investigational drug being developed for the treatment of FL. Study doctors put the participants in 1 of 5 groups, called treatment arms. Each group receives a different treatment. Around 1095 adult participants with previously untreated FL will be enrolled in approximately 250 sites across the world. Participants will receive R2 (intravenous \[IV\] infusion of rituximab (R) and oral capsules of lenalidomide) alone or in combination with subcutaneous injections of epcoritamab. Participants may also receive investigator's choice chemoimmunotherapy (CIT): IV infusion of obinutuzumab (G) and IV injections of cyclophosphamide, IV injections of doxorubicin, IV injections of vincristine, oral tablets of prednisone (CHOP) \[G-CHOP\]/ R-CHOP or G and IV infusion of bendamustine (Benda) \[G-Benda\]/R-Benda. The total treatment duration will be 120 weeks for all arms except A2, which is 24 weeks of treatment. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Feb 2024
Longer than P75 for phase_3
264 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedStudy Start
First participant enrolled
February 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2037
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2037
June 2, 2026
June 1, 2026
13.7 years
December 20, 2023
June 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Arm A1 vs Arm B: Percentage of Participants who Achieve Complete Response rate at 30 months (CR30)
CR30 will be determined by positron emission tomography-computerized tomography (cat scan) \[PET-CT\] per Lugano 2014 criteria, as assessed by independent review committee (IRC).
Up to 30 Months
Arm A1 vs Arm B: Number of Participants with Progression-free survival (PFS)
PFS is defined as the time from randomization until disease progression determined by Lugano 2014 criteria per IRC, or death, whichever occurs first.
Up to 10 Years
Secondary Outcomes (94)
Arm A1 vs Arm B: Overall Survival (OS)
Up to 10 Years
Arm A1 vs Arm B: Rate of Minimal Residual Disease (MRD) Negativity Rate
Up to 10 Years
Arm A1 vs Arm B: Change from Baseline in Physical Functioning (PF) According to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer (EORTC QLQ-C30)
21 Weeks
Arm A1 vs Arm A2: Percentage of Participants who Achieve CR30
Up to 30 Months
Arm A1 vs Arm C: Percentage of Participants who Achieve CR30
Up to 30 Months
- +89 more secondary outcomes
Study Arms (5)
Arm A1: Epcoritamab + Lenalidomide and Rituximab (R2)
EXPERIMENTALParticipants will receive epcoritamab in combination with R2 (ER2), followed by epcoritamab during the 120 week treatment duration.
Arm A2: Epcoritamab + Lenalidomide and Rituximab (R2)
EXPERIMENTALParticipants will receive epcoritamab in combination with R2 (ER2), during the 24 week treatment duration.
Arm B: Chemoimmunotherapy (CIT) Option A
EXPERIMENTALParticipants will receive CIT Option A (obinutuzumab (G) and cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) \[G-CHOP\]/ rituximab (R)-CHOP during the 120 week treatment duration.
Arm B: Chemoimmunotherapy (CIT) Option B
EXPERIMENTALParticipants will receive CIT Option B (G and bendamustine (Benda) \[G-Benda\]/R-Benda during the 120 week treatment duration.
Arm C: Lenalidomide and Rituximab (R2)
EXPERIMENTALParticipants will receive lenalidomide and rituximab (R2) during the 120 week treatment duration.
Interventions
Subcutaneous (SC) Injection
Oral Tablet
Intravenous (IV) Infusion
Oral Capsule
IV Infusion
Eligibility Criteria
You may qualify if:
- Diagnosis of follicular lymphoma (FL).
- Have CD20+, histologically confirmed classic FL (previously Grade 1 to 3a FL) at most recent representative tumor biopsy based on the local pathology report, according to the 5th edition of World Health Organization (WHO) Classification of Haematolymphoid Tumours.
- Are willing and able to comply with procedures required in the protocol.
- Must have stage, III, IV or II with bulky disease \>= 7cm).
- Must be in need of systemic treatment per investigator, as evidenced by meeting at least one of the Groupe d'Etude des Lymphomes Folliculaire (GELF) criteria.
- Has one or more target lesions:
- A positron emission tomography (PET)/computerized tomography (CT) scan demonstrating PET-positive lesion(s), and
- \>=1 measurable nodal lesion (long axis \>1.5cm) or \>=1 measurable extra-nodal lesion (long axis \>1.0 cm) on CT scan or MRI
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
- Able to receive at least one of the standard of care chemoimmunotherapy (CIT) treatment regimens: \[Arm B\] at the discretion of the Investigator, and rituximab and lenalidomide (R2) \[Arm C\].
- Have laboratory values meeting the criteria in the protocol.
You may not qualify if:
- Had major surgery within 4 weeks prior to randomization.
- Have active cytomegalovirus (CMV) disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (266)
UCSF Fresno /ID# 264712
Fresno, California, 93701-2302, United States
Scripps Mercy Hospital /ID# 265393
San Diego, California, 92103, United States
Sansum Clinic Research /ID# 261596
Santa Barbara, California, 93105, United States
Rocky Mountain Cancer Centers - Boulder /ID# 261203
Boulder, Colorado, 80303, United States
Christiana Care Health Service /ID# 261207
Newark, Delaware, 19713, United States
Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 262445
Jacksonville, Florida, 32256, United States
Advent Health /ID# 261578
Orlando, Florida, 32803, United States
Orlando Health Cancer Institute /ID# 260983
Orlando, Florida, 32806, United States
Moffitt Cancer Center /ID# 259487
Tampa, Florida, 33612-9416, United States
Beacon Cancer Care - Coeur d'Alene /ID# 260670
Coeur d'Alene, Idaho, 83814, United States
Northwestern Medicine - Northwestern Memorial Hospital /ID# 259814
Chicago, Illinois, 60611, United States
Cancer Care Specialists Of Central Illinois /ID# 272464
Decatur, Illinois, 62526, United States
Loyola University /ID# 259462
Maywood, Illinois, 60153, United States
Illinois Cancer Care, PC /ID# 261526
Peoria, Illinois, 61615, United States
Fort Wayne Medical Oncology and Hematology- South Office /ID# 259583
Fort Wayne, Indiana, 46804, United States
University of Iowa Health Care /ID# 262132
Des Moines, Iowa, 50314-3017, United States
University of Louisville Hospital /ID# 260544
Louisville, Kentucky, 40202, United States
Norton Cancer Institute - St. Matthews /ID# 261076
Louisville, Kentucky, 40207, United States
New England Cancer Specialists - Westbrook /ID# 260672
Westbrook, Maine, 04092, United States
University of Maryland, Baltimore /ID# 259538
Baltimore, Maryland, 21201, United States
Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 259476
Bethesda, Maryland, 20817, United States
St. Luke's Hospital - Chesterfield /ID# 260489
Chesterfield, Missouri, 63017, United States
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana /ID# 260006
Billings, Montana, 59102, United States
Nebraska Cancer Specialists (NCS) - Regional Cancer Center - St Francis Location /ID# 262506
Grand Island, Nebraska, 68803, United States
NHO - Nebraska Hematology-Oncology /ID# 269692
Lincoln, Nebraska, 68506, United States
Nebraska Cancer Specialists - Omaha - Wright Street /ID# 262505
Omaha, Nebraska, 68130, United States
University of Nebraska Medical Center /ID# 261996
Omaha, Nebraska, 68198, United States
University of New Mexico /ID# 261083
Albuquerque, New Mexico, 87102-4517, United States
Presbyterian Kaseman Hospital /ID# 262451
Albuquerque, New Mexico, 87110, United States
Presbyterian Rust Medical Center /ID# 262447
Rio Rancho, New Mexico, 87124, United States
New York Oncology Hematology - Albany Cancer Center /ID# 261814
Albany, New York, 12206-5013, United States
NYU Langone Hospital - Long Island /ID# 265531
Mineola, New York, 11501, United States
NYU Langone Medical Center /ID# 264518
New York, New York, 10016-6402, United States
Icahn School of Medicine at Mount Sinai /ID# 259595
New York, New York, 10029, United States
New York Oncology Hematology /ID# 270208
Troy, New York, 12180, United States
Clinical Research Alliance - Westbury /ID# 261078
Westbury, New York, 11590, United States
Novant Health Presbyterian Medical Center /ID# 259740
Charlotte, North Carolina, 28204, United States
Novant Health Forsyth Medical Center /ID# 259741
Winston-Salem, North Carolina, 27103, United States
Oncology Hematology Care, Inc - Blue Ash /ID# 261204
Cincinnati, Ohio, 45252, United States
Taylor Cancer Research Center /ID# 260488
Maumee, Ohio, 43537-1921, United States
Oncology Associates of Oregon, P.C. /ID# 261816
Eugene, Oregon, 97401, United States
MUSC Hollings Cancer Center /ID# 259604
Charleston, South Carolina, 29425, United States
Prisma Health /ID# 259602
Greenville, South Carolina, 29605, United States
Sarah Cannon Research Institute - Tristar Centennial Medical Center /ID# 274985
Nashville, Tennessee, 37203, United States
Texas Oncology - Austin Midtown /ID# 261208
Austin, Texas, 78705, United States
Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 261206
Dallas, Texas, 75246-2003, United States
MD Anderson Cancer Center /ID# 260984
Houston, Texas, 77030-4000, United States
Oncology Consultants /ID# 268390
Houston, Texas, 77030, United States
Joe Arrington Cancer Research /ID# 260382
Lubbock, Texas, 79410, United States
Intermountain Healthcare LDS Hospital /ID# 259759
Salt Lake City, Utah, 84143, United States
Virginia Cancer Specialists - Fairfax /ID# 261205
Fairfax, Virginia, 22031, United States
Oncology and Hematology Associates of Southwest Virginia /ID# 261592
Roanoke, Virginia, 98684, United States
Swedish Cancer Institute - Edmonds /ID# 266356
Edmonds, Washington, 98026, United States
Swedish Cancer Institute - Issaquah /ID# 266358
Issaquah, Washington, 98029, United States
Vista Oncology - East Olympia /ID# 261360
Olympia, Washington, 98506-5028, United States
Virginia Mason Hospital & Medical Center /ID# 260549
Seattle, Washington, 98101, United States
Swedish Medical Center - Seattle /ID# 260370
Seattle, Washington, 98104, United States
Northwest Medical Specialties - Tacoma /ID# 262133
Tacoma, Washington, 98405, United States
Royal Prince Alfred Hospital /ID# 259320
Camperdown, New South Wales, 2050, Australia
Liverpool Hospital /ID# 259321
Liverpool, New South Wales, 2170, Australia
Peter MacCallum Cancer Center /ID# 260431
Melbourne, New South Wales, 3000, Australia
Westmead Hospital /ID# 261465
Westmead, New South Wales, 2145, Australia
Townsville University Hospital /ID# 259323
Douglas, Queensland, 4814, Australia
Royal Brisbane and Women's Hospital /ID# 259326
Herston, Queensland, 4029, Australia
Princess Alexandra Hospital - Woolloongabba /ID# 259329
Woolloongabba, Queensland, 4102, Australia
Peninsula Private Hospital /ID# 259325
Frankston, Victoria, 3199, Australia
Fiona Stanley Hospital /ID# 259324
Murdoch, Western Australia, 6150, Australia
Royal Perth Hospital /ID# 259319
Perth, Western Australia, 6000, Australia
Algemeen Ziekenhuis klina /ID# 260324
Brasschaat, Antwerpen, 2930, Belgium
Uza /Id# 260319
Edegem, Antwerpen, 2650, Belgium
Cliniques Universitaires UCL Saint-Luc /ID# 260311
Brussels, Brussels Capital, 1200, Belgium
Groupe Sante CHC - Clinique du MontLegia /ID# 260325
Liège, Liege, 4000, Belgium
UZ Gent /ID# 260312
Ghent, Oost-Vlaanderen, 9000, Belgium
Universitair Ziekenhuis Leuven /ID# 260304
Leuven, Vlaams-Brabant, 3000, Belgium
AZ-Delta. /ID# 260313
Roeselare, West-Vlaanderen, 8800, Belgium
DF Star /ID# 260844
Brasília, Federal District, 70390-140, Brazil
Oncocentro de Minas Gerais /ID# 260973
Belo Horizonte, Minas Gerais, 30360-680, Brazil
Hospital Erasto Gaertner /ID# 260871
Curitiba, Puerto Rico, 81520-060, Brazil
Hospital Amaral Carvalho - Fundacao Doutor Amaral Carvalho /ID# 260828
Jaú, São Paulo, 17210-070, Brazil
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto /ID# 260843
Ribeirão Preto, São Paulo, 14049-900, Brazil
Fundacao Antonio Prudente - AC Camargo Cancer Center /ID# 260827
São Paulo, São Paulo, 01509-900, Brazil
Grupo Oncoclínicas Botafogo /ID# 260870
Rio de Janeiro, 22250-905, Brazil
Real e Benemérita Associação Portuguesa de Beneficência /ID# 260826
São Paulo, 01323-001, Brazil
Instituto D'Or de Pesquisa e Ensino - Regional Sao Paulo /ID# 260829
São Paulo, 01401-002, Brazil
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 260822
São Paulo, 05403-000, Brazil
UMHAT Dr Georgi Stranski EAD /ID# 260763
Pleven, 5800, Bulgaria
Acibadem City Clinic Tokuda University Hospital EAD /ID# 260685
Sofia, 1407, Bulgaria
UMHAT Sveti Ivan Rilski /ID# 259277
Sofia, 1431, Bulgaria
SHAT Hematologic Diseases /ID# 260457
Sofia, 1797, Bulgaria
Victoria Hospital /ID# 260770
London, Ontario, N6A 4L6, Canada
The Ottawa Hospital - General Campus /ID# 264470
Ottawa, Ontario, K1H 8L6, Canada
CSSS Alphonse-Desjardins, CHAU de Levis /ID# 260527
Lévis, Quebec, G6V 3Z1, Canada
Centre Hospitalier de l'Universite de Montreal (CHUM) /ID# 260617
Montreal, Quebec, H2X 0C1, Canada
Disc_Royal Victoria Hospital / McGill University Health Centre /ID# 261075
Montreal, Quebec, H4A 3J1, Canada
Peking University First Hospital /ID# 259816
Beijing, Beijing Municipality, 100034, China
Peking University Third Hospital /ID# 259806
Beijing, Beijing Municipality, 100191, China
The First Affiliated Hospital of Xiamen University /ID# 260014
Xiamen, Fujian, 361003, China
Sun Yat-Sen University Cancer Center /ID# 260478
Guangzhou, Guangdong, 510060, China
Guangdong Provincial Peoples Hospital /ID# 260446
Guangzhou, Guangdong, 510080, China
Zhujiang Hospital of Southern Medical University /ID# 260558
Guangzhou, Guangdong, 510280, China
Nanfang Hospital of Southern Medical University /ID# 260795
Guangzhou, Guangdong, 510515, China
Shenzhen People's Hospital /ID# 260137
Shenzhen, Guangdong, 518020, China
Affiliated Cancer Hospital of Guangxi Medical University /ID# 260537
Nanning, Guangxi, 530021, China
People's Hospital of Henan Province /ID# 259619
Zhengzhou, Henan, 450003, China
Henan Cancer Hospital /ID# 259618
Zhengzhou, Henan, 450008, China
Union Hospital affiliated to Tongji Medical College of Huazhong University of Sc /ID# 259743
Wuhan, Hubei, 430048, China
Hubei Cancer Hospital /ID# 260506
Wuhan, Hubei, 430079, China
Hunan Cancer Hospital /ID# 260439
Changsha, Hunan, 410006, China
The First Affiliated Hospital of Soochow University /ID# 260507
Suzhou, Jiangsu, 215006, China
The First Affiliated Hospital of Nanchang University /ID# 260556
Nanchang, Jiangxi, 330006, China
Jiangxi Provincial Cancer Hospital /ID# 260559
Nanchang, Jiangxi, 330029, China
First Affiliated Hospital of China Medical University /ID# 260217
Shenyang, Liaoning, 110001, China
Shandong Cancer Hospital /ID# 260808
Jinan, Shandong, 251601, China
Fudan University Cancer Hospital /ID# 260564
Shanghai, Shanghai Municipality, 200032, China
West China Hospital, Sichuan University /ID# 260015
Chengdu, Sichuan, 610041, China
Tianjin Cancer Hospital /ID# 259807
Tianjin, Tianjin Municipality, 300000, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 259616
Tianjin, Tianjin Municipality, 300020, China
The Affiliated Cancer Hospital of Xinjiang Medical University /ID# 260644
Ürümqi, Xinjiang, 830000, China
Yunnan Cancer Hospital /ID# 260645
Kunming, Yunnan, 650118, China
The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 259744
Hangzhou, Zhejiang, 310003, China
Zhejiang Cancer hospital /ID# 259742
Hangzhou, Zhejiang, 310022, China
The First Affiliated Hospital of Wenzhou Medical University /ID# 260566
Wenzhou, Zhejiang, 325000, China
Clinical Hospital Dubrava /ID# 260452
Zagreb, City of Zagreb, 10000, Croatia
Klinicka bolnica Merkur /ID# 260393
Zagreb, City of Zagreb, 10000, Croatia
Klinicki bolnicki centar Sestre milosrdnice /ID# 260456
Zagreb, City of Zagreb, 10000, Croatia
Klinicki bolnicki centar Zagreb /ID# 260364
Zagreb, City of Zagreb, 10000, Croatia
Klinicki bolnicki centar Rijeka /ID# 260455
Rijeka, Primorje-Gorski Kotar County, 51000, Croatia
Klinicki Bolnicki Centar (KBC) Split /ID# 260454
Split, Split-Dalmatia County, 21000, Croatia
Zadar General Hospital /ID# 260837
Zadar, 23000, Croatia
Fakultni Nemocnice Brno - Jihlavska /ID# 260571
Brno, Brno-mesto, 625 00, Czechia
Fakultni nemocnice Hradec Kralove - Sokolska /ID# 260560
Hradec Králové, 500 05, Czechia
Fakultni nemocnice Kralovske Vinohrady /ID# 260572
Prague, 100 34, Czechia
Rigshospitalet /ID# 260779
Copenhagen Ø, Capital Region, 2100, Denmark
Regionshospitalet Godstrup /ID# 260778
Herning, Central Jutland, 7400, Denmark
Roskilde Sygehus /ID# 260780
Roskilde, Region Sjælland, 4000, Denmark
Odense University Hospital /ID# 260777
Odense, Region Syddanmark, 5000, Denmark
Vejle Sygehus /ID# 260781
Vejle, Region Syddanmark, 7100, Denmark
CHU de CAEN - Hopital de la Cote de Nacre /ID# 260875
Caen, Calvados, 14033, France
CHU Brest - Hopital de la Cavale Blanche /ID# 260601
Brest, Finistere, 29200, France
Hopital Prive du Confluent /ID# 260596
Nantes, Loire-Atlantique, 44277, France
Centre Hospitalier D'Avignon /ID# 260511
Avignon, Provence-Alpes-Côte d'Azur Region, 84000, France
HCL - Hopital Lyon Sud /ID# 260508
Pierre-Bénite, Rhone, 69495, France
Centre Hospitalier du Mans /ID# 260510
Le Mans, Sarthe, 72037, France
CH Libourne - Hopital Robert Boulin /ID# 261478
Libourne, 33500, France
Hopital Saint-Louis /ID# 260509
Paris, 75010, France
Clinique Sainte-Anne /ID# 261528
Strasbourg, 67085, France
Hopital Prive d'Antony /ID# 260598
Antony, Île-de-France Region, 92160, France
Staedtisches Klinikum Karlsruhe /ID# 260348
Karlsruhe, Baden-Wurttemberg, 76133, Germany
Universitaetsklinikum Frankfurt /ID# 260388
Frankfurt am Main, Hesse, 60590, Germany
Klinikum Kassel /ID# 260432
Kassel, Hesse, 34125, Germany
St.-Antonius-Hospital /ID# 260520
Eschweiler, North Rhine-Westphalia, 52249, Germany
Klinikum Ludwigshafen /ID# 260688
Ludwigshafen am Rhein, Rhineland-Palatinate, 67063, Germany
Otto-von-Guericke-Universitaet /ID# 260425
Magdeburg, Saxony-Anhalt, 39120, Germany
Olympion General Clinic /ID# 262395
Pátrai, Achaia, 26443, Greece
General Hospital of Athens Laiko /ID# 259708
Athens, Attica, 11527, Greece
University General Hospital Attikon /ID# 260855
Athens, Attica, 12462, Greece
General University Hospital of Alexandroupolis /ID# 260858
Alexandroupoli, 68100, Greece
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 259709
Athens, 10676, Greece
Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 260051
Győr, Győr-Moson-Sopron, 9024, Hungary
Tolna Varmegyei Balassa Janos Korhaz /ID# 260048
Szekszárd, Tolna County, 7100, Hungary
Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 260050
Szombathely, Vas County, 9700, Hungary
Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 260049
Budapest, 1097, Hungary
Orszagos Onkologiai Intezet /ID# 260052
Budapest, 1122, Hungary
Meir Medical Center /ID# 259938
Kfar Saba, Central District, 4428164, Israel
Rabin Medical Center. /ID# 268328
Petah Tikva, Central District, 4941492, Israel
HaEmek Medical Center /ID# 259936
Afula, Haifa District, 1834111, Israel
Hadassah /ID# 259935
Jerusalem, Jerusalem, 91120, Israel
Soroka University Medical Center /ID# 259937
Beersheba, Southern District, 8443901, Israel
The Chaim Sheba Medical Center /ID# 259934
Ramat Gan, Tel Aviv, 5265601, Israel
Tel Aviv Sourasky Medical Center /ID# 259933
Tel Aviv, Tel Aviv, 6423906, Israel
IRCCS Istituto Clinico Humanitas /ID# 260887
Rozzano, Lombardy, 20089, Italy
Istituto di Candiolo Fondazione del Piemonte per l'Oncologia IRCCS /ID# 260889
Candiolo, Torino, 10060, Italy
IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 260886
Bologna, 40138, Italy
AOU Policlinico G. Rodolico - San Marco /ID# 260890
Catania, 95123, Italy
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello /ID# 260888
Palermo, 90146, Italy
AUSL di Reggio Emilia - Arcispedale Santa Maria Nuova /ID# 260744
Reggio Emilia, 42122, Italy
Fondazione Policlinico Universitario Campus Bio-Medico /ID# 260891
Roma, 00128, Italy
Fujita Health University Hospital /ID# 264679
Toyoake, Aichi-ken, 470-1192, Japan
Matsuyama Red Cross Hospital /ID# 266426
Matsuyama, Ehime, 790-8524, Japan
University of Fukui Hospital /ID# 265680
Yoshida-gun, Fukui, 910-1104, Japan
National Hospital Organization Kyushu Cancer Center /ID# 265960
Fukuoka, Fukuoka, 811-1395, Japan
Kyushu University Hospital /ID# 267861
Fukuoka, Fukuoka, 812-8582, Japan
Fukushima Medical University Hospital /ID# 264994
Fukushima, Fukushima, 960-1295, Japan
Chugoku Central Hospital /ID# 266520
Fukuyama, Hiroshima, 720-0001, Japan
Sapporo Medical University Hospital /ID# 265031
Sapporo, Hokkaido, 060-8543, Japan
Kobe City Medical Center General Hospital /ID# 266379
Kobe, Hyōgo, 650-0047, Japan
Hitachi General Hospital /ID# 265676
Hitachi-shi, Ibaraki, 317-0077, Japan
Kitasato University Hospital /ID# 264675
Sagamihara-shi, Kanagawa, 252-0375, Japan
Kanagawa Cancer Center /ID# 265497
Yokohama, Kanagawa, 241-8515, Japan
Okayama University Hospital /ID# 267135
Okayama, Okayama-ken, 700-8558, Japan
Kansai Medical University Hospital /ID# 266019
Hirakata-shi, Osaka, 573-1191, Japan
Kindai University Hospital /ID# 265038
Sakai-shi, Osaka, 590-0197, Japan
Tokyo Metropolitan Komagome Hospital /ID# 267692
Bunkyo Ku, Tokyo, 113-8677, Japan
The University of Tokyo Hospital /ID# 266422
Bunkyo-ku, Tokyo, 113-8654, Japan
Yamaguchi University Hospital /ID# 265619
Ube, Yamaguchi, 755-8505, Japan
University of Yamanashi Hospital /ID# 264677
Chuo-shi, Yamanashi, 409-3898, Japan
Aomori Prefectural Central Hospital /ID# 265692
Aomori, 030-0913, Japan
Chiba Cancer Center /ID# 267316
Chiba, 260-0801, Japan
Bravis Ziekenhuis /ID# 259055
Roosendaal, North Brabant, 4708 AE, Netherlands
Elisabeth Tweesteden Ziekenhuis /ID# 261239
Tilburg, North Brabant, 5022 GC, Netherlands
Olvg /Id# 259543
Amsterdam, North Holland, 1091 AC, Netherlands
Leids Universitair Medisch Centrum /ID# 259049
Leiden, South Holland, 2333 ZA, Netherlands
Franciscus Gasthuis & Vlietland, Locatie Gasthuis /ID# 259052
Rotterdam, South Holland, 3045 PM, Netherlands
HagaZiekenhuis /ID# 261220
The Hague, South Holland, 2545 AA, Netherlands
St. Antonius Ziekenhuis /ID# 259053
Nieuwegein, Utrecht, 3435 CM, Netherlands
Rijnstate /ID# 261219
Arnhem, 6815 AD, Netherlands
Universitair Medisch Centrum Groningen /ID# 259051
Groningen, 9713 GZ, Netherlands
Auckland City Hospital /ID# 259330
Grafton, Auckland, 1023, New Zealand
North Shore Hospital /ID# 260824
Takapuna, Auckland, 0622, New Zealand
Aidport sp z o.o. /ID# 267717
Poznan, Greater Poland Voivodeship, 60-175, Poland
Pratia MCM Krakow /ID# 260075
Krakow, Lesser Poland Voivodeship, 30-727, Poland
Narodowy Instytut Onkologii im. M. Sklodowskiej /ID# 260861
Warsaw, Masovian Voivodeship, 02-781, Poland
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopern /ID# 260633
Lodz, Łódź Voivodeship, 93-513, Poland
Swietokrzyskie Centrum Onkologii Samodzielny Publiczny Zaklad Opieki Zdrowotnej /ID# 260170
Kielce, Świętokrzyskie Voivodeship, 25-734, Poland
Fundacao Champalimaud /ID# 259652
Lisbon, Lisbon District, 1400-038, Portugal
Unidade Local de Saude de Gaia/Espinho /ID# 259655
Vila Nova de Gaia, Porto District, 4434-502, Portugal
Unidade Local de Saude de Santa Maria /ID# 259650
Lisbon, 1649-035, Portugal
Instituto Portugues de Oncologia do Porto Francisco Gentil /ID# 259649
Porto, 4200-072, Portugal
Pan American Center for Oncology Trials, LLC /ID# 260265
Rio Piedras, 00935, Puerto Rico
Auxilio Mutuo Cancer Center /ID# 260262
San Juan, 00918, Puerto Rico
Fundeni Clinical Institute /ID# 260296
Bucharest, Bucharest, 022328, Romania
Institutul Oncologic Prof Dr. Ion Chiricuta Cluj Napoca /ID# 259704
Cluj-Napoca, Cluj, 400015, Romania
Institutul Regional de Oncologie /ID# 259697
Iași, Iaşi, 700483, Romania
Spitalul Clinic Coltea /ID# 259699
Bucharest, 030171, Romania
Clinical Hospital Center Zvezdara /ID# 260900
Belgrade, Beograd, 11000, Serbia
University Clinical Center Serbia /ID# 259271
Belgrade, Beograd, 11000, Serbia
University Clinical Center Kragujevac /ID# 259274
Kragujevac, Sumadijski Okrug, 34000, Serbia
Institute for Oncology of Vojvodina /ID# 260223
Kamenitz, Vojvodina, 21208, Serbia
University Clinical Center Vojvodina /ID# 259272
Novi Sad, 21000, Serbia
Narodny onkologicky ustav /ID# 260638
Bratislava, Bratislava Region, 833 10, Slovakia
Univerzitna nemocnica Martin /ID# 260631
Martin, Žilina Region, 036 01, Slovakia
Wits Clinical Research /ID# 260958
Johannesburg, Gauteng, 1864, South Africa
Alberts Cellular Therapy /ID# 260514
Pretoria, Gauteng, 0044, South Africa
Haemalife Inc. /ID# 260513
Kuils River, Western Cape, 7580, South Africa
Seoul National University Bundang Hospital /ID# 260009
Seongnam-si, Gyeonggido, 13620, South Korea
Seoul National University Hospital /ID# 260007
Seoul, Seoul Teugbyeolsi, 03080, South Korea
Asan Medical Center /ID# 260010
Seoul, Seoul Teugbyeolsi, 05505, South Korea
Samsung Medical Center /ID# 260008
Seoul, Seoul Teugbyeolsi, 06351, South Korea
Instituto Catalan de Oncologia (ICO) Badalona /ID# 260495
Badalona, Barcelona, 08916, Spain
Institut Catala dOncologia (ICO) - LHospitalet /ID# 261439
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Hospital Universitario Marques de Valdecilla /ID# 260497
Santander, Cantabria, 39008, Spain
Clinica Universidad de Navarra - Pamplona /ID# 260496
Pamplona, Navarre, 31008, Spain
Hospital Universitario Vall de Hebron /ID# 260490
Barcelona, 08035, Spain
Hospital Clinic de Barcelona /ID# 260492
Barcelona, 08036, Spain
Hospital Santa Creu i Sant Pau /ID# 260498
Barcelona, 08041, Spain
Hospital San Pedro de Alcantara /ID# 260502
Cáceres, 10003, Spain
CLINICA UNIVERSIDAD DE NAVARRA-Madrid /ID# 261512
Madrid, 28027, Spain
MD Anderson Madrid /ID# 260500
Madrid, 28033, Spain
Hospital Universitario de Salamanca /ID# 260491
Salamanca, 37711, Spain
Sodra Alvsborgs sjukhus /ID# 261168
Borås, Västra Götaland County, 501 82, Sweden
Sahlgrenska Universitetssjukhuset /ID# 266600
Gothenburg, Västra Götaland County, 41346, Sweden
China Medical University Hospital /ID# 260357
Taichung, 40447, Taiwan
Taichung Veterans General Hospital /ID# 260361
Taichung, 40705, Taiwan
National Cheng Kung University Hospital /ID# 260363
Tainan, 704, Taiwan
National Taiwan University Hospital /ID# 260341
Taipei, 100, Taiwan
Istanbul Florence Nightingale Hospital /ID# 271291
Şişli, Istanbul, 34381, Turkey (Türkiye)
Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 259804
Istanbul, 34899, Turkey (Türkiye)
Ege Universitesi Tip Fakultesi /ID# 259803
Izmir, 35100, Turkey (Türkiye)
Kocaeli University Med Faculty /ID# 259717
Kocaeli, 41380, Turkey (Türkiye)
Ondokuz Mayis Universitesi /ID# 259713
Samsun, 55139, Turkey (Türkiye)
University Hospitals Plymouth NHS Trust /ID# 262671
Plymouth, Devon, PL6 8DH, United Kingdom
Hammersmith Hospital /ID# 261124
London, England, W12 0HS, United Kingdom
Queen Alexandra Hospital /ID# 269708
Portsmouth, Hampshire, PO6 3LY, United Kingdom
Leeds Teaching Hospitals NHS Trust /ID# 260466
Leeds, West Yorkshire, LS9 7TF, United Kingdom
The Christie Hospital /ID# 260463
Manchester, M20 4BX, United Kingdom
The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 260792
Newcastle upon Tyne, NE3 3HD, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ABBVIE INC.
AbbVie
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2023
First Posted
January 5, 2024
Study Start
February 5, 2024
Primary Completion (Estimated)
November 1, 2037
Study Completion (Estimated)
November 1, 2037
Last Updated
June 2, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/
- Access Criteria
- To learn more about the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/
AbbVie is committed to responsible clinical trial data sharing. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information (e.g., protocols, analyses plans, clinical study reports), as long as the trials are not part of an ongoing or planned regulatory submission. This includes requests for clinical trial data for unlicensed products and indications.